CU23759A3 - Composiciones inmunogénicas - Google Patents

Composiciones inmunogénicas

Info

Publication number
CU23759A3
CU23759A3 CU20080216A CU20080216A CU23759A3 CU 23759 A3 CU23759 A3 CU 23759A3 CU 20080216 A CU20080216 A CU 20080216A CU 20080216 A CU20080216 A CU 20080216A CU 23759 A3 CU23759 A3 CU 23759A3
Authority
CU
Cuba
Prior art keywords
composition
antigen
immune response
immunogenic compositions
vaccine
Prior art date
Application number
CU20080216A
Other languages
English (en)
Inventor
William Ross Heath
Gabrielle Therese Belz
Original Assignee
Inst Medical W & E Hall
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Medical W & E Hall filed Critical Inst Medical W & E Hall
Publication of CU23759A3 publication Critical patent/CU23759A3/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención está relacionada con una composición inmunogénica para levantar una respuesta inmune frente a un antígeno, la composición que comprende el antígeno y la entidad de direccionamiento específica para células dendríticas residentes en la linfa. El uso de la composición inmunogénica en una vacuna y los métodos para potenciar la respuesta inmune utilizando la composición también se proporcionan. En contraste, la invención está relacionada con una composición inmunogénica para levantar una respuesta inmune frente a un antígeno, donde la composición comprende el antígeno y una entidad de direccionamiento específica para células dendríticas derivadas de tejido y una vacuna que comprende dicha composición.
CU20080216A 2006-05-19 2008-11-19 Composiciones inmunogénicas CU23759A3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80199806P 2006-05-19 2006-05-19

Publications (1)

Publication Number Publication Date
CU23759A3 true CU23759A3 (es) 2012-01-31

Family

ID=38722861

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20080216A CU23759A3 (es) 2006-05-19 2008-11-19 Composiciones inmunogénicas

Country Status (8)

Country Link
US (1) US20090304735A1 (es)
EP (1) EP2018182A4 (es)
CN (1) CN101489589A (es)
AU (1) AU2007252296A1 (es)
CA (1) CA2652426A1 (es)
CU (1) CU23759A3 (es)
NZ (1) NZ572808A (es)
WO (1) WO2007134385A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8062852B2 (en) 2007-10-01 2011-11-22 The Children's Hospital And Regional Medical Center Detection and treatment of autoimmune disorders
EP2576602B1 (en) 2010-05-28 2020-02-12 Spixia Biotechnology AB Chimeric momp antigen, method and use
CA2826060C (en) * 2011-02-04 2019-06-18 Zoetis Llc Immunogenic bordetella bronchiseptica compositions
RU2571925C2 (ru) * 2011-04-12 2015-12-27 Интервет Интернэшнл Б.В. Метапневмовирус птиц в онколизисе
US20140221613A1 (en) * 2011-08-04 2014-08-07 Daicel Corporation Novel modified protein comprising tandem-type multimer of mutant extracellular domain of protein g
WO2014190838A1 (zh) * 2013-05-31 2014-12-04 普莱柯生物工程股份有限公司 一种猪伪狂犬病病毒、疫苗组合物及其制备方法和应用
CN103923884B (zh) * 2014-02-21 2017-03-29 普莱柯生物工程股份有限公司 一种猪伪狂犬病病毒基因缺失株、疫苗组合物及其制备方法和应用
CN104250640A (zh) 2014-08-22 2014-12-31 普莱柯生物工程股份有限公司 猪伪狂犬病病毒基因缺失株、疫苗组合物及其制备方法和应用
JP2018536023A (ja) * 2015-10-22 2018-12-06 モデルナティーエックス， インコーポレイテッド 単純ヘルペスウイルスワクチン
GB201605210D0 (en) * 2016-03-29 2016-05-11 Oxford Immunotec Ltd Assay
CN106047902B (zh) * 2016-05-26 2020-05-08 河北农业大学 一种基因gBabc
JP2019519589A (ja) * 2016-06-29 2019-07-11 デューク ユニバーシティー キメラポリオウイルスで抗原提示細胞を活性化するための組成物及び方法
CN108276476B (zh) * 2017-12-27 2019-11-22 东北农业大学 一种鸡骨髓源树突状细胞靶向肽sp及其用途
WO2019149265A1 (zh) * 2018-02-01 2019-08-08 厦门大学 一种用于***的伪狂犬病毒

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8273357B2 (en) * 2004-07-16 2012-09-25 Massachusetts Institute Of Technology Antigen-carbohydrate conjugates

Also Published As

Publication number Publication date
CA2652426A1 (en) 2007-11-29
WO2007134385A1 (en) 2007-11-29
US20090304735A1 (en) 2009-12-10
CN101489589A (zh) 2009-07-22
NZ572808A (en) 2011-11-25
AU2007252296A1 (en) 2007-11-29
EP2018182A1 (en) 2009-01-28
EP2018182A4 (en) 2010-10-06

Similar Documents

Publication Publication Date Title
CU23759A3 (es) Composiciones inmunogénicas
MY150706A (en) Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant
ME01199B (me) Nove kompozicije adjuvanta
CO6751287A2 (es) Composición antigénetica de micobacteria
CL2006000880A1 (es) Composicion inmunogena para causar una respuesta inmunologica contra una especie helicobacter y circovirus porcino que comprende antigenos de dichos patogenos; metodo para inducir una respuesta inmunologica contra dichos patogenos; kit para preparar la composicion inmunogena.
MX2010001054A (es) Composiciones adyuvantes antigenicas y metodos.
CO6382137A2 (es) Oligonucleótidos inmunoestimuladores
AR057237A1 (es) Metodos y composiciones para actuar sobre la poliubiquitina
AR052498A1 (es) Vacuna
DK1898948T3 (da) Polyriboinosinsyre-polyribocytidylsyre-baseret adjuvans
CR20160206A (es) Composiciones y métodos para anticuerpos que se dirigen a la proteína de complemento C5
BRPI0708344B8 (pt) vetores adenovirais quiméricos e composição imunogênica
CO6382189A2 (es) Anticuerpos anti-cd79b e inmunoconjugados y metodos de uso
CR20120310A (es) Anticuerpos neutralizadores contra el receptor de prolactina y su uso terapéutico
BRPI1013780A2 (pt) composições para imunização contra staphylococcus aureus.
MY143347A (en) Mucosal immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant
MX2013001527A (es) Nuevas vacunas adyuvantes en base a adyuvantes de orientacion para anticuerpos directamente hacia celulas presentadoras de antigenos.
MX2007002787A (es) Adyuvante de glicosilceramida para antigenos de sacarido.
BRPI0511026C1 (pt) uso de um los neisserial, e, composição
CL2011000382A1 (es) Uso de una composicion inmunogenica que comprende una cantidad eficaz de un virus de sindrome disgenesico y respiratorio porcino (prrs) tipo ii para disminuir la incidencia, gravedad o prevenir los efectos de una enfermedad con fiebre alta de prrs.
AR080111A1 (es) Metodos y composiciones de inmunizacion
CL2015001111A1 (es) Composición coadyuvante que comprende un hidrato de carbono unido al quitosano formando una base de schiff; formulación de vacuna que la comprende; método de elaboración; y uso de la vacuna.
AR059851A1 (es) Anticuerpos de la egfl7 y metodos de uso
AR059096A1 (es) Anticuerpos anti- efrina -b2 y metodos que usan estos
AR051826A1 (es) Composiciones inmunogenicas de antigenos polipeptidicos de staphylococcus epidermidis

Legal Events

Date Code Title Description
FG Grant of patent